What's New

17/03/2017
3SBio 2016 Annual Results Investor Conference Call

 presentation Presentation

11/10/2016
EXCLUSIVE LICENSE AGREEMENT WITH ASTRAZENECA IN RESPECT OF BYETTA AND BYDUREON

pdfdownPDF Download

22/08/2016
3SBio Interim Results Investor Conference Call

 presentation Presentation

31/03/2016
3SBio Annual Results Investor Conference Call

 presentation Presentation

07/03/2016
3SBio's PEG-irinotecan Wins IND Approval From China FDA

pressreleasePress Release

04/03/2016

3SBio Inc. Announces Expansion of its Leadership Team


pressreleasePress Release

24/09/2015
3SBio 2015 Interim Report

pdfdownPDF Download

interimreport

01/09/2015
3SBio 2015 Interim Results Investor Presentation

presentation Presentation

01/06/2015
Prospectus

pdfdownPDF Download  

Application Forms: pdfdownGreen pdfdownWhite pdfdownYellow

Prospectus Cover EN Thumbnail

26/01/2015
3SBio Acquires Sirton Pharmaceuticals SpA

pressreleasePress Release

Stock price

 

Contacts

Investor Relations / Media Enquiries: ir@3sbio.com

Principal Share Registrar
and Transfer Office

Codan Trust Company (Cayman) Limited
Cricket Square, Hutchins Drive
PO Box 2681
Grand Cayman, KY1-1111
Cayman Islands

Hong Kong Share Registrar

Computershare Hong Kong Investor Services Limited
Shops 1712-1716, 17th Floor
Hopewell Centre, 183 Queen's Road East
Wanchai, Hong Kong

Headquarters

No. 3 A1, Road 10
Shenyang Economy and Technology Development Zone
Shenyang, PRC

Principle Place of Business
in Hong Kong

36/F, Tower Two, Times Square
1 Matheson Street
Causeway Bay, Hong Kong

3SBio Investor Relations

Room 3529
35/F Central Plaza
18 Harbour Road
Wanchai, Hong Kong
Tel: (852) 2593-1243